Remus Pharmaceuticals Ltd vs Roopa Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Remus Pharmaceuticals Ltd is ₹ 715.4 as of 06 May 15:30 . The P/E Ratio of Remus Pharmaceuticals Ltd is 49.4 as of March 2024 .The P/E Ratio of Roopa Industries Ltd is 0 as of March 2024 . The Market Cap of Remus Pharmaceuticals Ltd is ₹ 1016 crore as of March 2024 .The Market Cap of Roopa Industries Ltd is ₹ 0 crore as of March 2024 . The revenue of Remus Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Roopa Industries Ltd for the Dec '25 is ₹ 33.54 crore as compare to the Sep '25 revenue of ₹ 28.75 crore. This represent the growth of 16.66% The ebitda of Remus Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Roopa Industries Ltd for the Dec '25 is ₹ 2.03 crore as compare to the Sep '25 ebitda of ₹ 1.64 crore. This represent the growth of 23.78% The net profit of Remus Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Roopa Industries Ltd changed from ₹ 0.27 crore to ₹ 0.77 crore over 7 quarters. This represents a CAGR of 82.00% The Dividend Payout of Remus Pharmaceuticals Ltd changed from 2.56 % on March 2023 to 4.44 % on March 2025 . This represents a CAGR of 20.15% over 3 yearsThe Dividend Payout of Roopa Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

About Roopa Industries Ltd

Roopa Industries Limited is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Chemicals to various countries.
The Company was incorporated in 1985 and operates into manufacturing and marketing of bulk drugs and intermediaries.
The Company became a manufacturer of Neutraceuticals, Fine chemicals, Drug Intermediates and Bulk Drugs since 1998.
Over the years, it has been a principal supplier to many companies in various countries. The Company handled critical and risky processes and have dependable technical expertise for carrying out any labyrinthine hazardous manufacturing operations.
It offers triphenyl phosphine for use as wittig reagent in the manufacture of pharmaceuticals and cosmetics; as catalyst in hydroformylation, isomerisation, and polymerisation of olefins; as catalysing and curing agent in a range of polymerization reactions, epoxy resins, and photopolymers; and as reducing and deoxygenating agent in quinones, epoxides, amine oxides, and sulfoxides.

FAQs for the comparison of Remus Pharmaceuticals Ltd and Roopa Industries Ltd

Which company has a larger market capitalization, Remus Pharmaceuticals Ltd or Roopa Industries Ltd?

Market cap of Remus Pharmaceuticals Ltd is 843 Cr while Market cap of Roopa Industries Ltd is 42 Cr

What are the key factors driving the stock performance of Remus Pharmaceuticals Ltd and Roopa Industries Ltd?

The stock performance of Remus Pharmaceuticals Ltd and Roopa Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Remus Pharmaceuticals Ltd and Roopa Industries Ltd?

As of May 6, 2026, the Remus Pharmaceuticals Ltd stock price is INR ₹715.4. On the other hand, Roopa Industries Ltd stock price is INR ₹54.42.

How do dividend payouts of Remus Pharmaceuticals Ltd and Roopa Industries Ltd compare?

To compare the dividend payouts of Remus Pharmaceuticals Ltd and Roopa Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.